Exposure to enriched environments during adolescence prevents abnormal behaviours associated with histone deacetylation in phencyclidine-treated mice

International Journal of Neuropsychopharmacology

Volumn 15, Issue 10, 2012, Pages 1489-1501

  Koseki, Takenao ^a   Mouri, Akihiro ^a   Mamiya, Takayoshi ^a   Aoyama, Yuki ^a   Toriumi, Kazuya ^a   Suzuki, Shizuka ^a   Nakajima, Azusa ^a   Yamada, Takuma ^a   Nagai, Taku ^b   Nabeshima, Toshitaka ^a  

^a MEIJO UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Enriched environment; histone acetylation; phencyclidine; schizophrenia

Indexed keywords

BUTYRIC ACID; HISTONE DEACETYLASE 5; HISTONE H3; LYSINE; PHENCYCLIDINE;

ADOLESCENT; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BODY WEIGHT; CHILD BEHAVIOR; COGNITIVE DEFECT; CONTROLLED STUDY; DEACETYLATION; ENRICHED ENVIRONMENT; HISTONE DEACETYLATION; HISTONE MODIFICATION; LOCOMOTION; MALE; MEMORY; MOUSE; NONHUMAN; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSOCIAL ENVIRONMENT; SCHIZOPHRENIA; SOCIAL BEHAVIOR; SOCIAL DISABILITY; SOCIAL INTERACTION;

AGE FACTORS; ANIMALS; ENVIRONMENT; HISTONE DEACETYLASES; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PHENCYCLIDINE; PSYCHOMOTOR AGITATION; SOCIAL BEHAVIOR;

EID: 84867263831     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001672     Document Type: Article

References (50)

1. Abi-Saab WM, D'Souza DC, Moghaddam B, Krystal JH (1998). The NMDA antagonist model for schizophrenia : promise and pitfalls. Pharmacopsychiatry 31, 104-109.
2. Adlard PA, Perreau VM, Pop V, Cotman CW (2005). Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. Journal of Neuroscience 25, 4217-4221.
3. Allen RM, Young SJ (1978). Phencyclidine-induced psychosis. American Journal of Psychiatry 135, 1081-1084.
4. Belforte JE, Zsiros V, Sklar ER, Jiang Z, et al. (2010). Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nature Neuroscience 13, 76-83.
5. Bezard E, Dovero S, Belin D, Duconger S, et al. (2003). Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine : involvement of dopamine transporter and trophic factors. Journal of Neuroscience 23, 10999-11007.
6. Bliss TV, Collingridge GL (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
7. Chapillon P, Manneche C, Belzung C, Caston J (1999). Rearing environmental enrichment in two inbred strains of mice: 1. Effects on emotional reactivity. Behavior Genetics 29, 41-46.
8. Chawla S, Vanhoutte P, Arnold FJ, Huang CL, et al. (2003). Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5. Journal of Neurochemistry 85, 151-159.
9. Duffy SN, Craddock KJ, Abel T, Nguyen PV (2001). Environmental enrichment modifies the PKA-dependence of hippocampal LTP and improves hippocampusdependent memory. Learning and Memory 8, 26-34.
10. Faherty CJ, Kerley D, Smeyne RJ (2003). A Golgi-Cox morphological analysis of neuronal changes induced by environmental enrichment. Brain Research, Developmental Brain Research 141, 55-61.
11. Fischer A, Sananbenesi F, Wang X, Dobbin M, et al. (2007). Recovery of learning and memory is associated with chromatin remodelling. Nature 447, 178-182.
12. Franklin KBJ, Paxinos G (1997). The Mouse Brain in Stereotaxic Coordinates. San Diego: Academic Press.
13. Gavin DP, Kartan S, Chase K, Grayson DR, et al. (2008). Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects. Schizophrenia Research 103, 330-332.
14. Gavin DP, Rosen C, Chase K, Grayson DR, et al. (2009). Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. Journal of Psychiatry and Neuroscience 34, 232-237.
15. Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry 148, 1301-1308.
16. Kazantsev AG, Thompson LM (2008). Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nature Reviews. Drug Discovery 7, 854-868.
17. Kozorovitskiy Y, Gross CG, Kopil C, Battaglia L, et al. (2005). Experience induces structural and biochemical changes in the adult primate brain. Proceedings of the National Academy of Sciences USA 102, 17478-17482.
18. Laviola G, Hannan AJ, Macr̀ S, Solinas M, et al. (2008). Effects of enriched environment on animal models of neurodegenerative diseases and psychiatric disorders. Neurobiology of Disease 31, 159-168.
19. Lehrmann E, Colantuoni C, Deep-Soboslay A, Becker KG, et al. (2006). Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse. PLoS One 27, e114.
20. Leggio MG,Mandolesi L, Federico F, Spirito F, et al. (2005). Environmental enrichment promotes improved spatial abilities and enhanced dendritic growth in the rat. Behavioural Brain Research 163, 78-90.
21. Lewis DA, Mirnics K (2006). Transcriptome alterations in schizophrenia : disturbing the functional architecture of the dorsolateral prefrontal cortex. Progress in Brain Research 158, 141-152.
22. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, et al. (1959). Study of a new schizophrenomimetic drug; sernyl. AMA Archives of Neurology and Psychiatry 81, 363-369.
23. McGuffin P, Owen MJ, Farmer AE (1995). Genetic basis of schizophrenia. Lancet 346, 678-682.
24. Maddox VH, Godefroi EF, Parcell RF (1965). The synthesis of phencyclidine and other 1-arylcyclohexylamines. Journal of Medicinal Chemistry 56, 230-235.
25. Meijer MK, Sommer R, Spruijt BM, van Zutphen LF, et al. (2007). Influence of environmental enrichment and handling on the acute stress response in individually housed mice. Laboratory Animals 41, 161-173.
26. Molina V, Solera S, Sanz J, Sarramea F, et al. (2009). Association between cerebral metabolic and structural abnormalities and cognitive performance in schizophrenia. Psychiatry Research 173, 88-93.
27. Mouri A, Noda Y, Enomoto T, Nabeshima T (2007a). Phencyclidine animal models of schizophrenia : approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochemistry International 51, 173-184.
28. Mouri A, Noda Y, Noda A, Nakamura T, et al. (2007b). Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2 +calmodulindependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine. Molecular Pharmacology 71, 1598-1609.
29. Murai R, Noda Y, Matsui K, Kamei H, et al. (2007). Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: implications for abnormalities of glutamate release and NMDA-CaMKII signaling. Behavioural Brain Research 180, 152-160.
30. Nagai T, Murai R, Matsui K, Kamei H, et al. (2009). Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors. Psychopharmacology 202, 315-328.
31. Noda Y, Yamada K, Furukawa H, Nabeshima T (1995). Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia. British Journal of Pharmacology 116, 2531-2517.
32. Pratt JA, Winchester C, Egerton A, Cochran SM, et al. (2008). Modelling prefrontal cortex deficits in schizophrenia : implications for treatment. British Journal of Pharmacology 153, 465-470.
33. Qiao H, Noda Y, Kamei H, Nagai T, et al. (2001). Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment. Neuroreport 12, 11-15.
34. Raine A, Mellingen K, Liu J, Venables P, et al. (2003). Effects of environmental enrichment at ages 3-5 years on schizotypal personality and antisocial behavior at ages 17 and 23 years. American Journal of Psychiatry 160, 1627-1635.
35. Rainey Jr. JM, Crowder MK (1975). Prolonged psychosis attributed to phencyclidine : report of three cases. American Journal of Psychiatry 132, 1076-1078.
36. Renthal W, Maze I, Krishnan V, Covington III HE, et al. (2007). Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 56, 517-529.
37. Rosenzweig MR, Bennett EL (1996). Psychobiology of plasticity : effects of training and experience on brain and behavior. Behavioural Brain Research 78, 57-65.
38. Rosenzweig MR, Bennett EL, Hebert M, Morimoto H (1978). Social grouping cannot account for cerebral effects of enriched environments. Brain Research 153, 563-576.
39. Segovia G, del Arco A, de Blas M, Garrido P, et al. (2010). Environmental enrichment increases the in vivo extracellular concentration of dopamine in the nucleus accumbens: a microdialysis study. Journal of Neural Transmission 117, 1123-1130.
40. Segovia G, del Arco A, Mora F (2009). Environmental enrichment, prefrontal cortex, stress, and aging of the brain. Journal of Neural Transmission 116, 1007-1016.
41. Sharma RP, Rosen C, Kartan S, Guidotti A, et al. (2006). Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder : preliminary results from a clinical population. Schizophrenia Research 88, 227-231.
42. Soares de Alencar Mota C, Ribeiro C, de Araujo GG, de Araujo MB, et al. (2008). Exercise training in the aerobic/anaerobic metabolic transition prevents glucose intolerance in alloxan-treated rats. BMC Endocrine Disorders 8, 11.
43. Tang YP, Wang H, Feng R, Kyin M, et al. (2001). Differential effects of enrichment on learning and memory function in NR2B transgenic mice. Neuropharmacology 41, 779-790.
44. Tsankova N, Renthal W, Kumar A, Nestler EJ (2007). Epigenetic regulation in psychiatric disorders. Nature Reviews, Neuroscience 8, 355-367.
45. Tsankova NM, Berton O, Renthal W, Kumar A, et al. (2006). Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nature Neuroscience 9, 519-525.
46. van Dellen A, Blakemore C, Deacon R, York D, et al. (2000). Delaying the onset of Huntington's in mice. Nature 404, 721-722.
47. van Os J, Rutten BP, Poulton R (2008). Gene-environment interactions in schizophrenia : review of epidemiological findings and future directions. Schizophrenia Bulletin 34, 1066-1082.
48. Vieira VJ, Valentine RJ, Wilund KR, Woods JA (2009). Effects of diet and exercise on metabolic disturbances in high-fat diet-fed mice. Cytokine 46, 339-345.
49. Wiedholz LM, Owens WA, Horton RE, Feyder M, et al. (2008). Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors. Molecular Psychiatry 13, 631-640.
50. Zhao MG, Toyoda H, Lee YS, Wu LJ, et al. (2005). Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory. Neuron 47, 859-872.